CARBOLIEVA 450 MG (Carboplatin Injection IP 450 mg) is a prescription anticancer medicine containing Carboplatin 450 mg, a platinum-based chemotherapy agent used in the treatment of various cancers. Carboplatin belongs to the class of Platinum Coordination Compounds, which work by damaging the DNA of cancer cells and preventing their growth, multiplication, and spread.

Carboplatin is widely used in oncology because of its proven effectiveness and comparatively favorable safety profile when compared to some other platinum-based chemotherapy agents. It interferes with cancer cell DNA by forming cross-links that prevent proper DNA replication and transcription, ultimately leading to cancer cell death.

CARBOLIEVA 450 MG is commonly prescribed as a single-agent therapy or as part of combination chemotherapy regimens for the treatment of ovarian cancer, lung cancer, head and neck cancer, breast cancer, and several other solid tumors.

The medicine is administered intravenously under the supervision of qualified healthcare professionals experienced in cancer treatment.

CARBOLIEVA 450 MG is commonly used for:

• Ovarian Cancer
• Non-Small Cell Lung Cancer (NSCLC)
• Small Cell Lung Cancer (SCLC)
• Head and Neck Cancer
• Breast Cancer
• Cervical Cancer
• Endometrial Cancer
• Germ Cell Tumors
• Solid Tumors
• Combination Chemotherapy Programs

Manufactured according to stringent pharmaceutical quality standards, CARBOLIEVA 450 MG is designed to ensure consistent quality, safety, and therapeutic effectiveness.

Patients receiving Carboplatin therapy require routine monitoring of blood counts, kidney function, liver function, and overall health status to ensure optimal treatment outcomes.

Due to its broad clinical utility and established efficacy, CARBOLIEVA 450 MG remains an important medicine in modern oncology care.

CARBOLIEVA 450 MG (Carboplatin Injection IP 450 mg) is primarily used in the treatment and management of various cancers.

Common Uses of CARBOLIEVA 450 MG

1. Ovarian Cancer

Carboplatin is one of the most commonly prescribed chemotherapy medicines for ovarian cancer treatment.

2. Lung Cancer

The medicine is used in both non-small cell and small cell lung cancer treatment regimens.

3. Head and Neck Cancer

Doctors may prescribe Carboplatin as part of combination chemotherapy protocols.

4. Breast Cancer

The medicine may be used in selected breast cancer treatment plans.

5. Cervical Cancer

Carboplatin may be incorporated into advanced cervical cancer treatment programs.

6. Germ Cell Tumors

The medicine is used in certain germ cell tumor treatment regimens.

7. Other Solid Tumors

Carboplatin is utilized in various oncology treatment protocols depending on clinical requirements.

How CARBOLIEVA 450 MG Works

Carboplatin belongs to a class of medicines known as Platinum-Based Anticancer Agents.

CARBOLIEVA works by:

• Binding to cancer cell DNA
• Forming DNA cross-links
• Preventing DNA replication
• Inhibiting cancer cell division
• Triggering cancer cell death
• Slowing tumor growth and progression

This mechanism helps control cancer development and supports effective disease management.

Like all medicines, CARBOLIEVA 450 MG may cause side effects in some patients. The severity and frequency of side effects vary among individuals.

Common Side Effects

1. Low Blood Cell Counts

Reduction in white blood cells, red blood cells, and platelets may occur.

2. Nausea and Vomiting

Digestive discomfort is commonly reported during treatment.

3. Fatigue

Weakness and tiredness may develop.

4. Loss of Appetite

Some patients may experience decreased appetite.

5. Increased Risk of Infection

Lower white blood cell counts may increase susceptibility to infections.

6. Easy Bruising or Bleeding

Reduced platelet counts may contribute to bleeding tendencies.

7. Electrolyte Imbalances

Changes in electrolyte levels may occur during therapy.

8. Mild Kidney Function Changes

Regular monitoring is recommended throughout treatment.

9. Weakness

Generalized weakness may occur in some patients.

Serious Side Effects

Seek immediate medical attention if you experience:

• Severe allergic reactions
• Persistent fever
• Serious infections
• Significant bleeding
• Difficulty breathing
• Severe bone marrow suppression
• Severe kidney problems
• Unusual bruising
• Persistent vomiting or dehydration

Patients should contact their healthcare provider immediately if serious symptoms occur.

The dosage of CARBOLIEVA 450 MG (Carboplatin Injection IP 450 mg) should always be determined by a qualified oncologist.

Factors Affecting Dosage

1. Type of Cancer

Treatment recommendations vary according to the disease being treated.

2. Body Surface Area (BSA)

Dosage calculations may be based on body surface area.

3. Kidney Function

Renal function is an important consideration for Carboplatin dosing.

4. Blood Test Results

Laboratory monitoring helps guide dosage adjustments.

5. Combination Chemotherapy

Concurrent medicines may influence treatment schedules.

Important Dosage Instructions

• The medicine should only be administered by qualified healthcare professionals.
• Follow all scheduled chemotherapy sessions.
• Attend routine blood tests and monitoring appointments.
• Inform your doctor about unusual symptoms during treatment.
• Maintain adequate hydration as advised by your healthcare provider.
• Do not miss oncology follow-up visits.

Precautions Before Using CARBOLIEVA 450 MG

Before starting treatment, inform your doctor if you have:

• Kidney disease
• Liver disease
• Blood disorders
• Active infections
• Previous reactions to platinum-based chemotherapy
• Allergies to Carboplatin or related medicines

Important Monitoring Requirements

Patients receiving Carboplatin therapy may require:

• Complete blood count monitoring
• Kidney function tests
• Liver function assessments
• Electrolyte monitoring
• Regular medical examinations

Patients should also disclose all prescription medicines, vitamins, supplements, and herbal products they are taking to avoid potential drug interactions.

Pregnant and breastfeeding women should not use this medicine unless specifically advised by a healthcare professional.

Storage Instructions

• Store according to manufacturer recommendations.
• Protect from excessive heat and light.
• Keep out of reach of children.
• Handle under appropriate pharmaceutical conditions.

Why Choose CARBOLIEVA 450 MG?

• Contains high-quality Carboplatin 450 mg
• Effective platinum-based anticancer therapy
• Widely used in ovarian and lung cancer treatment
• Suitable for combination chemotherapy regimens
• Manufactured under strict pharmaceutical quality standards
• Reliable therapeutic performance
• Supports modern oncology treatment protocols
• Designed for advanced cancer management

Frequently Asked Questions (FAQs)

What is CARBOLIEVA 450 MG used for?

It is used for the treatment of ovarian cancer, lung cancer, breast cancer, cervical cancer, head and neck cancer, and other solid tumors.

What is Carboplatin?

Carboplatin is a platinum-based chemotherapy medicine that damages cancer cell DNA and prevents tumor growth.

Is CARBOLIEVA 450 MG chemotherapy?

Yes. Carboplatin is a widely used platinum-based chemotherapy agent.

Does CARBOLIEVA 450 MG affect blood counts?

Yes. It may reduce white blood cells, red blood cells, and platelet counts, requiring regular monitoring.

Can Carboplatin affect kidney function?

Yes. Kidney function monitoring is recommended during treatment.

Is regular monitoring necessary during therapy?

Yes. Blood counts, kidney function, and overall clinical assessments are important throughout treatment.

Can CARBOLIEVA 450 MG be used in combination chemotherapy?

Yes. It is frequently used alongside other anticancer medicines in established treatment protocols.

Should CARBOLIEVA 450 MG be administered under medical supervision?

Yes. This medicine should only be administered by qualified healthcare professionals experienced in oncology treatment.